These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9034628)

  • 21. Integration of single-layer skin hollow fibers and scaffolds develops a three-dimensional hybrid bioreactor for bioartificial livers.
    Zhang S; Chen L; Liu T; Wang Z; Wang Y
    J Mater Sci Mater Med; 2014 Jan; 25(1):207-16. PubMed ID: 23963686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioartificial liver support for fulminant hepatic failure.
    Anand AC
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S69-74. PubMed ID: 15025261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new concept of bioartificial liver based on a fluidized bed bioreactor.
    Doré E; Legallais C
    Ther Apher; 1999 Aug; 3(3):264-7. PubMed ID: 10427626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal liver support: waiting for the deciding vote.
    Adham M
    ASAIO J; 2003; 49(6):621-32. PubMed ID: 14655724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver.
    Sielaff TD; Nyberg SL; Rollins MD; Hu MY; Amiot B; Lee A; Wu FJ; Hu WS; Cerra FB
    Cell Biol Toxicol; 1997 Jul; 13(4-5):357-64. PubMed ID: 9298256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of the bioartificial liver: the need for randomized clinical trials.
    Nyberg SL; Peshwa MV; Payne WD; Hu WS; Cerra FB
    Am J Surg; 1993 Nov; 166(5):512-21. PubMed ID: 8238746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to supporting the failing liver.
    Cao S; Esquivel CO; Keeffe EB
    Annu Rev Med; 1998; 49():85-94. PubMed ID: 9509251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.
    Nagaki M; Miki K; Kim YI; Ishiyama H; Hirahara I; Takahashi H; Sugiyama A; Muto Y; Moriwaki H
    Dig Dis Sci; 2001 May; 46(5):1046-56. PubMed ID: 11341648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in bioartificial liver assist devices.
    Patzer JF
    Ann N Y Acad Sci; 2001 Nov; 944():320-33. PubMed ID: 11797681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute liver failure: liver support therapies.
    Stadlbauer V; Jalan R
    Curr Opin Crit Care; 2007 Apr; 13(2):215-21. PubMed ID: 17327745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of a flat membrane bioreactor as a bioartificial liver.
    De Bartolo L; Bader A
    Ann Transplant; 2001; 6(3):40-6. PubMed ID: 11899896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-based therapy for liver diseases.
    Di Campli C; Nestola M; Piscaglia AC; Santoliquido A; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2003; 7(2):41-4. PubMed ID: 12911118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model.
    Naka S; Takeshita K; Yamamoto T; Tani T; Kodama M
    Artif Organs; 1999 Sep; 23(9):822-8. PubMed ID: 10491029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.
    Zhang Z; Zhao YC; Cheng Y; Jian GD; Pan MX; Gao Y
    World J Gastroenterol; 2014 Dec; 20(46):17399-406. PubMed ID: 25516651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure.
    Riordan SM; Skouteris GG; Williams R
    Int J Artif Organs; 1998 Jun; 21(6):312-8. PubMed ID: 9714023
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with a porcine hepatocyte-based liver support system.
    Chen SC; Hewitt WR; Watanabe FD; Eguchi S; Kahaku E; Middleton Y; Rozga J; Demetriou AA
    Int J Artif Organs; 1996 Nov; 19(11):664-9. PubMed ID: 8970834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging the gap: advances in artificial liver support.
    Nyberg SL
    Liver Transpl; 2012 Nov; 18 Suppl 2():S10-4. PubMed ID: 22767444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
    Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects of the use of hepatic cells for extracorporeal liver support.
    Gerlach JC
    Acta Gastroenterol Belg; 2005; 68(3):358-68. PubMed ID: 16268424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.